TP53 and Mobius syndrome: While primary MBs have a relatively low frequency of somatic gene mutations, several groups have reported an increase in somatic mutational burden including mutations in TP53 and aberrant p53-Myc interactions in human MB samples collected after chemoradiotherapy (11, 15, 25).